Summary
First report of intravesical BPC-157 for interstitial cystitis. 80-100% symptom resolution at 6 weeks in patients unresponsive to pentosan polysulfate.
Study Details
Study Design
Pilot study
Indication
Interstitial cystitis
Intervention
Intravesical BPC-157 10 mg
Species
Human
Sample Size
12 subjects
Risk of Bias Assessment
Case reports only
Tags
SourceCase ReportBpc 157Cystitis